Tab. I.

Distinct clinicopathological features of type I and type II endometrial cancer

Parameter	Type I	Type II
Histopathological type	endometrioid	serous, clear-cell
Grading	G1-G2	G3
Prognosis	favourable	poor
Clinical course	non-aggressive	aggressive
Clinical stage at diagnosis (FIGO)	I-II	III-IV
Receptor positivity (oestrogens/progesterone)	+	–
Oestrogen associated	+	–
Endometrium	hyperplasia	atrophy
Metastases	seldom	frequent
Myometrial invasion	usually less than 1/2 of the uterine wall	deep
Sensitivity to hormonal therapy	+	–